193P A phase 1 study evaluating the pharmacokinetics (PK), safety, and efficacy of regorafenib (REG) in Chinese patients with advanced, refractory solid tumors
Titel:
193P A phase 1 study evaluating the pharmacokinetics (PK), safety, and efficacy of regorafenib (REG) in Chinese patients with advanced, refractory solid tumors
Auteur:
Cao, J. Ji, D. Shen, W. Wang, Q. Liu, Y. Lu, D. Sturm, I. Huang, F. Cleton, A.